Morphological Characteristics Of Schistosoma Mansoni Pzq-resistant And -susceptible Strains Are Different In Presence Of Praziquantel by Pinto-Almeida A. et al.
ORIGINAL RESEARCH
published: 26 April 2016
doi: 10.3389/fmicb.2016.00594
Frontiers in Microbiology | www.frontiersin.org 1 April 2016 | Volume 7 | Article 594
Edited by:
Octavio Luiz Franco,
Universidade Catolica de Brasilia,
Brazil
Reviewed by:
Osmar Nascimento Silva,
Dom Bosco Catholic University, Brazil
Ramar Perumal Samy,
National University of Singapore,
Singapore
*Correspondence:
Ana Afonso
anaafonso74@hotmail.com
Specialty section:
This article was submitted to
Antimicrobials, Resistance and
Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 29 December 2015
Accepted: 11 April 2016
Published: 26 April 2016
Citation:
Pinto-Almeida A, Mendes T, de
Oliveira RN, Corrêa SAP, Allegretti
SM, Belo S, Tomás A, Anibal FF,
Carrilho E and Afonso A (2016)
Morphological Characteristics of
Schistosoma mansoni PZQ-Resistant
and -Susceptible Strains Are Different
in Presence of Praziquantel.
Front. Microbiol. 7:594.
doi: 10.3389/fmicb.2016.00594
Morphological Characteristics of
Schistosoma mansoni PZQ-Resistant
and -Susceptible Strains Are
Different in Presence of Praziquantel
António Pinto-Almeida 1, 2, 3, Tiago Mendes 2, 4, Rosimeire Nunes de Oliveira 4,
Sheila de Andrade Penteado Corrêa 4, Silmara Marques Allegretti 4, Silvana Belo 2,
Ana Tomás 1, Fernanda de Freitas Anibal 5, Emanuel Carrilho 3 and Ana Afonso 2, 3, 5*
1Graduate Program in Areas of Basic and Applied Biology, Instituto de Ciências Biomédicas Abel Salazar, Universidade do
Porto, Porto, Portugal, 2Medical Parasitology Unit, Global Health and Tropical Medicine, Instituto de Higiene e Medicina
Tropical, Universidade Nova de Lisboa, Lisbon, Portugal, 3 Bioanalytical, Microfabrication, and Separations Group, Instituto
de Química de São Carlos, Universidade de São Paulo, São Carlos, Brazil, 4Departamento De Biologia Animal, Instituto de
Biologia, Universidade Estadual de Campinas, Campinas, Brazil, 5 Laboratory of Parasitology, Department of Morphology and
Pathology, Universidade Federal de São Carlos, São Carlos, Brazil
Schistosomiasis is one of the most common human parasitic diseases whose
socioeconomic impact is only surpassed by malaria. Praziquantel (PZQ) is the only
drug commercially available for the treatment of all schistosome species causing
disease in humans. However, there has been stronger evidences of PZQ-resistance
on Schistosoma mansoni and thus it is very important to study the phenotypic
characteristics associated with it. The aim of this study was to evaluate morphological
alterations in S. mansoni PZQ-resistant adult worms and eggs, by comparing a
PZQ- resistant strain obtained under PZQ drug pressure with a PZQ-susceptible strain.
For this, scanning electronic microscopy was used to assess tegumental responsiveness
of both strains under PZQ exposure, and optical microscopy allowed the monitoring of
worms and eggs in the presence of the drug. Those assays showed that PZQ-susceptible
worms exposed to the drug hadmore severe tegumental damages than the resistant one,
which had only minor alterations. Moreover, contrary to what occurred in the susceptible
strain, resistant worms were viable after PZQ exposure and gradually regaining full motility
after removal of the drug. Eggs from resistant strain parasites are considerably smaller
than those from susceptible strain. Our results suggest that there might be a difference
in the tegument composition of the resistant strain and that worms are less responsive
to PZQ. Changes observed in egg morphology might imply alterations in the biology of
schistosomes associated to PZQ-resistance, which could impact on transmission and
pathology of the disease. Moreover, we propose a hypothetical scenario where there is a
different egg tropism of the S. mansoni resistant strain. This study is the first comparing
two strains that only differ in their resistance characteristics, which makes it a relevant
step in the search for resistance determinants.
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INTRODUCTION
Schistosomiasis is a disease caused by blood fluke trematode,
Schistosoma spp., where Schistosoma haematobium, Schistosoma
japonicum, and Schistosoma mansoni are the three main species
affecting humans (Utzinger and Keiser, 2004; Gryseels et al.,
2006; Colley et al., 2014). S. mansoni is the most widespread,
being endemic in 54 countries, mostly in Africa and parts of
South America (Crompton, 1999; Chitsulo et al., 2000).
Schistosomiasis is considered one of the most common
human parasitic diseases whose socioeconomic impact is only
surpassed by malaria among all parasitic diseases. The disease
registers high rates of morbidity, in about 20 million people
and mortality about 280000 deaths annually, especially in
tropical and subtropical countries, namely Africa, Middle East,
Caribbean, Brazil, Venezuela, Suriname, and other countries
such as China, Indonesia and the Philippines [van der Werf
et al., 2003; Steinmann et al., 2006; Kamel et al., 2011; World
Health Organization (WHO), 2013]. It is a chronic parasitic
disease which is considered a neglected disease by the World
Health Organization. It has been estimated that approximately
249million people are infected worldwide, with 780million being
at risk of infection [Steinmann et al., 2006; Caffrey, 2007; World
Health Organization (WHO), 2013].
The disease transmission invariably occurs when people
suffering from schistosomiasis contaminate freshwater with their
excreta containing parasite eggs, which hatch in water. People
become infected when larval forms of the parasite (cercariae)
penetrate the skin during contact with freshwater, usually by
swimming or washing (Gautret et al., 2012).
Schistosome infections can cause severe damage to various
organs, mostly intestine, bladder, liver, brain and spinal cord,
and cause significant morbidity, impairs childhood development
and adult productivity, potentially increases susceptibility to
other infections such as HIV, and, in some cases, lead to death
(van der Werf et al., 2003; King and Dangerfield-Cha, 2008;
Hotez and Fenwick, 2009; King, 2010; Ndeffo Mbah et al., 2013;
Colley et al., 2014). Infrastructural and educational awareness
can be highly effective to control schistosomiasis (Tanaka and
Tsuji, 1997), however they are expensive and require levels
of organization that are difficult in most developing countries
(Greenberg, 2014). The use of molluscicides to eliminate
intermediate host snails is another important control method,
but it is also costly and often produces limited and short-term
effectiveness (Sturrock, 2001) as well as having some negative
environmental impact. Therefore, because there is no available
vaccine or prophylaxis, current control of schistosomiasis is
based only on chemotherapy using Praziquantel (PZQ) (Hotez
et al., 2007).
PZQ is the only antischistosomal drug commercially available
for the treatment of all human schistosome species (Cioli and
Pica-Mattoccia, 2003; Fenwick et al., 2006; Doenhoff et al., 2009;
Greenberg, 2014) and it presents important advantages such as
mild side effects and relatively low cost (Ndeffo Mbah et al.,
2013). PZQ has been available for several decades and large-scale
PZQ treatment programs have produced significant reductions
in both disease prevalence and intensity (Vennervald et al., 2005;
Toure et al., 2008; Sesay et al., 2014). However, dependence on
a single drug, which would be inadvisable for any infectious
condition, is in the case of a disease with such high prevalence as
schistosomiasis (Caffrey, 2007) a major concern, because it might
induce the appearance of drug-resistant/tolerant parasites (Fallon
et al., 1995; Gryseels et al., 2006; Doenhoff et al., 2008; Gryseels,
2012).
So far, the mechanism involved in the phenomenon of
resistance to PZQ is not yet fully understood, there is only
descriptions and evidences of this phenomenon in vivo and in
vitro studies. For instance, Fallon and Doenhoff (1994), produced
a S. mansoni PZQ-resistant strain in only two generations after
repeated exposure to sub-lethal doses of the drug through in
vivo artificial selection in mice. Furthermore, low cure rates in
response to PZQ emerged 10–15 years ago after mass scale use
in countries like Egypt and Senegal (Ismail et al., 1996; Doenhoff
et al., 2002) and worms from non-cured patients were repeatedly
less susceptible to PZQ when tested in mice (Cioli et al., 2004).
de Oliveira et al. (2012), evaluated the effect of PZQ on
the morphology of adult S. mansoni susceptible to PZQ and
observed that parasites exposed to the drug showed tegumental
changes apparent in all male and female worms. They observed
destruction of tubercles with loss of thorns and formation
of vesicles around the tubercles. Since the tegument of adult
Schistosoma is a protective sheath that plays a role in defense as
well as in the uptake of nutrients, osmoregulation and excretion,
damages in this structure may have major consequences to
parasite viability. Thus, morphological studies are important to
clarify aspects of drug-induced damage (El-Shabasy et al., 2015).
We have obtained in our laboratory by stepwise drug pressure
a PZQ-resistant parasite strain (IHMT-LISBON) from a fully
PZQ-susceptible parasite strain (Belo Horizonte, Brazil line).
This, S. mansoni variant strain is 12 times more resistant
to PZQ than the original susceptible one and this resistant
phenotype is stable in the absence of drug pressure. This
resistant parasite variant strain, obtained from infected mice,
tolerates up to 1200mg PZQ/kg of mouse body weight
and is isogenic to its fully susceptible parental counterpart,
except for the genetic determinants accounting for the PZQ-
resistance phenotype (Pinto-Almeida et al., 2015). Besides that,
data resulting from earlier study (Pinto-Almeida et al., 2015)
suggested that the S. mansoni PZQ-resistant strain has different
in vitro susceptibility to PZQ and that this difference varied
greatly between male and female worms. In this context, the
objective of this study was to evaluate morphological alterations
(phenotypic characteristics) in the S. mansoni PZQ-resistance
phenotype by comparing the PZQ-resistant strain obtained
under PZQ drug pressure with the PZQ-susceptible strain.
MATERIALS AND METHODS
Praziquantel
Praziquantel was purchased from Merck & Co. (Kenilworth, NJ,
USA) and dissolved in 1% dimethyl sulfoxide (DMSO) from
Sigma-Aldrich as described by Melman et al. (2009), used for
stock solution, which was subsequently diluted to appropriate
concentrations in culture media.
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Parasite Isolation and Animal Model
In this study we used two parasite strains, a S. mansoni BH
strain from Belo Horizonte, Minas Gerais, Brazil, susceptible
to PZQ, and a stable PZQ-resistant strain (IHMT-LISBON)
obtained from the BH strain as described by Pinto-Almeida
et al. (2015). Briefly, our stable PZQ-resistant parasite strain was
obtained from the PZQ-susceptible BH line submitted to various
steps of PZQ continuous drug pressure, starting with 300 mg/kg
and finishing with 1200 mg/ kg of PZQ. Infected CD1 mice
were checked approximately 60 days post parasite infection by
Kato-Katz procedure; if eggs were found in feces, mice were
then treated orally with PZQ solution at appropriate dosage.
If, on day 15, post PZQ treatment, viable eggs (verified by live
miracidia inside the eggs and Kato-Katz procedure) continued
to be eliminated, mice were euthanized and miracidia present in
the liver were used to subsequently infect Biomphalaria glabrata
snails. Once B. glabrata snails start eliminating S. mansoni
cercariae (30–60 days after snail infection), new CD1 mice were
re-infected and the previous procedure was repeated, continuing
the PZQ-resistant strain selection in vivo. PZQ dosage was
increased every two passages. These two parasite strains are
routinely kept in their intermediate host B. glabrata snails at
our laboratory at Instituto de Higiene e Medicina Tropical,
Universidade Nova de Lisboa.
Mus musculus CD1 line male mice are considered the choice
animal model for S. mansoni infection, because it is highly
susceptible to this parasite as it closely resembles the S. mansoni
human infection (Katz andCoelho, 2008). The infection occurred
by percutaneous exposure of mice tails to about 100 cercariae of
S. mansoni each, through natural transdermal penetration of the
cercariae (Lewis, 1998).
Adult worms (8–10 weeks post-infection) were collected
through hepatic portal system and mesenteric veins perfusion,
as described by Lewis (1998), washed in saline solution and then
maintained in a RPMI medium (Sigma-Aldrich). The Figure 1
explain in more detail the experimental design performed in this
study.
In vitro Treatment with Praziquantel
After collection, adult worm parasites were transferred to 24-
well culture plates containing RPMI-1640 culture medium, 200
mM L-glutamine, 10 mM HEPES, 24 mM de NaHCO3, 10000
UI of penicillin and 10 mg/mL of streptomycin, from Sigma-
Aldrich, pH 7, and supplemented with 15% fetal bovine serum.
About five parasites, individually or as a couple, were added
to each well and the same concentration of drug was used in
two wells. All experiments were carried out in tree biological
replicates, 10 on each replicate (n = 30) for each studied
group: (1) PZQ-susceptible male worms, (2) PZQ-susceptible
female worms, (3) PZQ-resistant male worms, (4) PZQ-resistant
female worms, (5) PZQ-susceptible couple worms, and (6) PZQ-
resistant couple worms. Parasites were incubated overnight at
37◦C in a 5% CO2 atmosphere to recover from stress caused
by perfusion. After this period, male and female worms were
treated in culture with a dosage of PZQ with impact in the
parasite, but with the guarantee of not killing them (0.3 µM)
for 3 h, then washed twice with saline solution to clean any
traces of culture medium and prepared for scanning electron
microscopy (SEM). Couple worms of both strains were treated
in vitro with a lethal dosage of PZQ (32 µM) for 48 h.
During this period, worms were analyzed and monitored under
an inverted optical microscope (DM-500, Leica), to evaluate
and monitor the motility and viability of the worms, and
morphological changes in eggs of the two parasite strains
studied in this work. For negative control of each group, worms
were kept in RPMI-1640 drug free medium, under the same
conditions.
Scanning Electron Microscopy
To evaluate tegumental morphologic changes in both strains
of S. mansoni after in vitro exposure to PZQ, adult worms
were analyzed using scanning electron microscopy as described
in de Oliveira et al. (2012, 2013, 2014). Briefly, worms were
incubated at 37◦C in a CO2 atmosphere (5%) for 24 h. After
incubation, the parasites were washed with 0.1 M sodium
cacodylate buffer (for 1 h, changing the solution every 15
min), fixed in 2.5% glutaraldehyde (pH 7.4) (Merck) for
24 h and then fixed in 1% osmium tetroxide for 1 h.
Specimens were dehydrated in increasing concentrations of
ethanol (50, 70, 80, 90, 95, and 100%) for 30 min each, dried
in a critical point dryer, mounted on stubs, metalized with
gold particles using Sputter Coater and finally analyzed and
photographed using an ultra-scanning electronmicroscope (Jeol-
JSM-820).
Ethics Statement
Animal housing was maintained at 25 ± 2◦C and 45–65%
relative humidity. All the animal experimental were approved
by the Ethics and Animal Welfare Committee (CEBEA),
Faculty of Veterinary Medicine, UTL (Ref. 0421/2013) and
performed according to the committee guidelines. Animals were
kept and handled in accordance with National and European
legislation (DL 276/2001 and DL 314/2003; 2010/63/EU adopted
on 22nd September 2010), with regard to animal protection
and welfare, and all procedures were performed according to
National and European legislation. The anesthetics and other
techniques were used to reduce the pain and adverse effect of
animal.
Statistical Analysis
Results were expressed as mean ± SD. Data was statistically
analyzed using the IBM SPSS Statistics software version
19.0 for Windows. Kolmogorov-Smirnov (Lilliefors significance
correction) and Shapiro-Wilk tests were used to analyse data
normality and Levene’s test was used to test homogeneity of
variance. After this we chose to use a parametric test—t-test for
independent samples, to compare the average size of the eggs
and lateral spines between PZQ-resistant and PZQ-susceptible
strains. On the other hand, due to the lack of normality of
the data and lack of homogeneity of variance, we used a non-
parametric test—Mann–Whitney (MW), to test whether there
was difference between the ratios of lateral spines/eggs on the two
strains studied. The level of significance was set at p < 0.05.
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FIGURE 1 | Schematic cartoon of the experimental design. (1) Biomphalaria glabrata snails (intermediate hosts of S. mansoni) release the infective form of the
parasite (cercariae) for human or other mammalian definitive hosts; (2) about 100 cercariae were used to infect the definitive host; (3) CD1 Mice were used as
definitive host in our experiment, and after 8–10 weeks post-infection they were sacrificed to collect adult worms of the parasite; (4) adult worms were obtained by
mice liver perfusion; (5) male and female worms were treated in 24-well culture plate with a dosage of PZQ (0.3 µM) with impact in the parasite but with the guarantee
of not killing them. These worms were prepared for tegumental alterations study using SEM; (6) couple worms were treated in 24-well culture plate with a lethal
dosage of PZQ (32 µM). These worms were analyzed and monitored under an inverted optical microscope.
FIGURE 2 | Monitoring of S. mansoni resistant strain adult worms submitted to 32 µM of PZQ during 48 h. (A) Adult worms from the resistant strain
exposed to PZQ, showing muscle contraction, and reduction of movements; (B) Adult worms from the resistant strain exposed to PZQ, showing muscle contraction,
and little movements (24 h after drug exposure); (C) Adult worms from the resistant strain exposed to PZQ, began to gain some motility by the end of the incubation
period (48 h); (D) Adult worms from the resistant strain not exposed to PZQ (negative control group—resistant worms kept in RPMI-1640 medium with no addition of
the drug); (E) Adult worms from the resistant strain not exposed to PZQ (negative control group—resistant worms kept in RPMI-1640 medium with no addition of the
drug), 24 h of incubation period; (F) Adult worms from the resistant strain not exposed to PZQ (negative control group—resistant worms kept in RPMI-1640 medium
with no addition of the drug), at the end of the incubation period (48 h).
RESULTS
In vitro Effect of PZQ on S. mansoni
PZQ-Resistant and -Susceptible Strains
The viability of the adult worms was analyzed during in vitro
incubation with a concentration of 32 µM of PZQ for a
48 h period. We observed that the viability of adult worms
resistant to PZQ and treated with this drug was similar to the
negative resistant control group (resistant worms kept in RPMI-
1640 drug free medium), in which all individuals were alive
after the incubation period. We noticed that upon exposure to
PZQ adult worms from the resistant strain retracted, showed
muscle contraction, reduction of movements (Figures 2A,B)
and, by the end of the incubation period, start regaining motility
(Figure 2C), in comparison to the control group (Figures 2D–F).
Still, the worms remained alive and, after removal of the medium
containing PZQ, they gradually regained full motility.
For susceptible parasites, where most of the worms were
dead after drug addition, the viability was much lower compared
to the negative susceptible control group (susceptible worms
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FIGURE 3 | Monitoring of S. mansoni susceptible strain adult worms
submitted to 32 µM of PZQ during 48 h. (A) Adult worms from the
susceptible strain exposed to PZQ, showing muscle contraction and reduction
of movements; (B) Adult worms from the susceptible strain dead after
exposed to PZQ, 24 h after exposure; (C) Adult worms from the susceptible
strain not exposed to PZQ (negative control group—susceptible worms kept in
RPMI-1640 medium with no addition of the drug); (D) Adult worms from the
susceptible strain not exposed to PZQ (negative control group—susceptible
worms kept in RPMI-1640 medium with no addition of the drug), 24 h of
incubation period.
kept in RPMI-1640 drug free medium) and the treated-resistant
parasite group. Susceptible strain parasites were more contracted
(Figure 3A) than those from the resistant isolate submitted to the
same PZQ dosage (Figures 2A,B). After exposure to PZQ, drug-
susceptible adult worms retracted, showed muscle contraction,
and reduction of movements (Figure 3A), in comparison to the
control group (Figures 3C,D), and dead after 24 h of incubation
period (Figure 3B). After removal of the medium containing
PZQ, they did not recover motility, contrary to what happened
with resistant strain parasites that gradually regained motility.
Regarding the egg morphology, it was different between
PZQ-resistant and PZQ-susceptible stains (Figure 4). Eggs from
resistant parasite females (Figures 4A,B, n = 7) were smaller
(p < 0.05) when compared to those from the susceptible strain
(Figures 4C,D, n = 7; Figure 5 and Table 1). Furthermore, we
found statistical significant differences in the size of the lateral
spines of the eggs, those from resistant strain females had smaller
and thicker lateral spines than those of susceptible worms (p <
0.05; Figure 5 and Table 1). In order to confirm that the observed
differences in lateral spine size were not a simple consequence
of smaller size of the egg in resistant worms, the ratio between
lateral spine and egg sizes was determined for resistant strain
and susceptible strain (Table 1). When the ratios (lateral spine
size/egg size) of the two strains were compared, we found a
significant difference (p < 0.05) between eggs from resistant
worms and susceptible worms, which mean that the difference
observed in the size of the lateral spine is not a consequence
of smaller size of the eggs. These are interesting findings
since it may have important repercussions on pathological and
symptomatology effects induced by this strain.
FIGURE 4 | Morphological difference between eggs from resistant
strain and susceptible strain. (A) Eggs from resistant strain parasites,
showing morphology alterations, smaller size, and smaller lateral spines (10x);
(B) Eggs from resistant strain, in a bigger scale, showing morphology
alterations, smaller size, and smaller lateral spines (40x); (C) Eggs from
susceptible strain parasites, showing normal morphology (10x); (D) Eggs from
susceptible strain parasites, showing normal morphology, in a bigger scale
(40x).
FIGURE 5 | Difference in egg morphology of S. mansoni resistant strain
and susceptible strain. Gray bars, measurements of eggs and lateral spines
from susceptible strain worms; Black bars, measurements of eggs and lateral
spines from resistant strain worms. Data was presented as mean ± SD.
Statistical analysis was performed by parametric t-test, for independent
simples, whose level of significance was set at p < 0.05. * indicated p < 0.05.
Effect of PZQ on Tegument of S. mansoni
PZQ-Resistant and -Susceptible Strains
We analyzed the presence of tegumental alterations in S. mansoni
PZQ-resistant strain adult worms and in the parental PZQ-
susceptible strain upon addition of 0.3 µM PZQ during 3 h,
using scanning electron microscopy. Significant changes were
only observed in males and female worms of the susceptible
strain. In susceptible males not exposed to PZQ, the oral
and ventral sucker (Figure 6A) and tegument (Figures 6B,C)
did not show any changes, while males exposed to the same
drug presented changes in acetabular sucker (Figure 7A),
tegument peeling (Figure 7B), and destruction of tubercles and
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TABLE 1 | Difference in egg morphology (size of the eggs and lateral spine and ratio between them) of S. mansoni resistant and susceptible parasites
(n = 7).
Egg morphology Size (µm) mean ± SD 95% Confidence limits p-value
Susceptible strain eggs 101.80 ± 2.99 99.03–104.57 p < 0.05 (t-test)
Resistant strain eggs 75.60 ± 8.98 67.29–83.91
Susceptible strain lateral spines 32.78 ± 2.75 30.24–35.33 p < 0.05 (t-test)
Resistant strain lateral spines 20.26 ± 4.73 15.88–24.64
Susceptible strain ratio (SS spine/SS egg) 0.32 ± 0.018 0.30–0.34 p < 0.05 (MW test)
Resistant strain ratio (RS spine/RS egg) 0.27 ± 0.036 0.23–0.29
SS, susceptible strain; RS, resistant strain.
FIGURE 6 | Scanning electron microscopy of S. mansoni
PZQ-susceptible strain. (A–C) Susceptible strain adult males of control
group kept in RPMI-1640 drug free medium for 3 h, showing normal
morphology of the tegument, and oral and ventral suckers; (D–F) Susceptible
strain adult females of control group kept in RPMI-1640 drug free medium for
3 h, showing normal morphology of the tegument, and oral and ventral
suckers. Image marginations: (A) 180x 10 kV ________100u; (B) 900x 10 kV
________10u; (C) 800x 10 kV ________10u; (D) 500x 10 kV ________10u; (E)
1200x 10 kV ________10u; (F) 3300x 10 kV ________10u.
spines (Figures 7C,D). Susceptible strain females not exposed
to PZQ showed normal morphology of ventral and oral
suckers (Figure 6D) and normal morphology of the tegument
(Figures 6E,F), but when exposed to the drug, presented muscle
contraction and corrugations (Figures 8A–C). Furthermore, they
showed alterations in the oral sucker (Figure 8D) and peeling of
some tegumental regions (Figures 8E,F).
Tegumental alterations induced by PZQ were not so
significant in the resistant strain, when compared to the
susceptible strain. As expected, the control group of resistant
males did not show any tegumental alterations, showing normal
morphology of the oral and ventral suckers (Figures 9A,B)
FIGURE 7 | Scanning electron microscopy of S. mansoni
PZQ-susceptible strain adult males after exposure to 0.3 µM of PZQ
for 3 h. (A) Susceptible strain adult males upon exposure to PZQ, presenting
changes in acetabular suckers; (B) tegument peeling; (C,D) destruction of
tubercles and spines. Red arrows indicate alterations. Image marginations: (A)
300x 10 kV ________100u; (B) 1200x 10 kV ________10u; (C) 800x 10 kV
________10u; (D) 850x 10 kV ________10u.
and tegument (Figures 9C–F). When exposed to PZQ, those
worms presented small alterations in some areas, such as
changes in oral and ventral suckers (Figures 10A–C), and
little alterations in the body surface, with losses of tubercles
and spines (Figures 10D–F). Similarly female resistant worms
control group did not present any tegumental damages, neither
in oral and ventral suckers (Figures 11A,B), nor in the tegument
(Figures 11C,D). Upon drug exposure, those worms only showed
very few alterations, namely, some morphological changes in the
oral sucker (Figure 12A), some light peeling in the worm ventral
region (Figure 12B), and alterations in some tegumental areas
(Figures 12C,D).
DISCUSSION
In past years, several studies have been performed in order to
demonstrate that resistance/tolerance to PZQ may occur and
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FIGURE 8 | Scanning electron microscopy of S. mansoni
PZQ-susceptible strain adult females after exposure to 0.3 µM of PZQ
for 3 h. (A–C) Susceptible strain adult females upon exposure to PZQ,
showing muscle contraction and corrugations; (D) alterations in oral sucker;
(E,F) peeling of some tegumental regions. Red arrows indicate alterations.
Image marginations: (A) 170x 10 kV ________100u; (B) 110x 10 kV
________100u; (C) 1000x 10 kV ________10u; (D) 500x 10 kV ________10u;
(E) 900x 10 kV ________10u; (F) 950x 10 kV ________10u.
is more than hypothetical (Fallon and Doenhoff, 1994; Ismail
et al., 1996; Doenhoff et al., 2002; Cioli et al., 2004). Our
group in particular had selected, by stepwise drug pressure, a
S. mansoni strain that is isogenic to its parental fully susceptible
counterpart, except for genetic determinants accounting for
the PZQ-drug resistance phenotype, and phenotypically similar
to the susceptible strain except in resistance. In the present
study, we took the advantage of the availability of these two
strains of S. mansoni and performed a comparative assessment
of morphological alterations that the in vitro effect of PZQ
can cause on S. mansoni PZQ-resistant parasites. William et al.
(2001) and Liang et al. (2001) have already performed studies
with PZQ-resistant isolates obtained from an Egyptian and
a Senegalese patient eggs, which were not cured by three
therapeutic doses of PZQ, where they demonstrated that isolates
from resistant infections were less susceptible to Praziquantel-
induced tegumental damage in vitro (William et al., 2001) and
Praziquantel-resistant isolates may be more pathogenic in mice
than the susceptible ones (Liang et al., 2001). However, as far as
we know, our study is the first report in which the in vitro effect of
PZQ on the morphological characteristics of a resistant strain of
S. mansoni can be compared with its parental susceptible strain.
Parameters, such as motor activity, eggs morphology, and
tegumental changes, are often evaluated as indicators of
FIGURE 9 | Scanning electron microscopy of S. mansoni PZQ-resistant
strain adult males of control group kept in RPMI-1640 drug free
medium for 3 h. (A,B) Resistant strain adult males kept in RPMI-1640 drug
free medium, showing normal morphology of the oral and ventral suckers;
(C–F) normal morphology of the tegument. Image marginations: (A) 70x 10 kV
________100u; (B) 170x 10 kV ________100u; (C) 1200x 10 kV ________10u;
(D) 950x 10 kV ________10u; (E) 2200x 10 kV ________10u; (F) 850x 10 kV
________10u.
biological activity in studies using schistosomes species (William
et al., 2001; Sanderson et al., 2002; Pica-Mattoccia and Cioli,
2004; De Araújo et al., 2007; Xiao et al., 2007; de Oliveira Penido
et al., 2008; Katz, 2008; Boissier et al., 2009; Magalhães et al.,
2009, 2010), hence we evaluate these parameters in order to
assess the effect of PZQ on adult S. mansoni PZQ-resistant and
PZQ-susceptible worms survival and fitness.
Our study shows that resistant strain worms have less
muscle contraction and movements after exposure to PZQ than
susceptible isolates. This complies with studies suggesting that
contraction of somatic musculature is a marked effect of addition
of PZQ to schistosomes in vitro (William et al., 2001), and
that worms resistant to PZQ in vivo have significantly reduced
contractile responses to PZQ in vitro (Ismail et al., 1996). It is
also evident that, after removal of the medium containing the
drug, resistant worms recover motility, unlike susceptible worms,
where the majority of which are dead.
The tegument is a very important organ for schistosomes,
for many reasons: it is important for the survival of the
worms in the host (Skelly and Wilson, 2006; Van Hellemon
et al., 2006; Moraes, 2012), protecting the parasite against
the action of the host’s immune system, absorbing nutrients
and molecules and participating in synthesis of some proteins
(Shuhua et al., 2000; Bertão et al., 2012; Reda et al., 2012). Some
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FIGURE 10 | Scanning electron microscopy of S. mansoni
PZQ-resistant strain adult males after exposure to 0.3 µM of PZQ for
3 h. (A–C) Resistant strain adult males upon exposure to PZQ, presenting
changes in oral and ventral suckers; (D–F) losses of tubercles and spines. Red
arrows indicate alterations. Image marginations: (A) 90x 10 kV ________100u;
(B) 250x 10 kV ________100u; (C) 160x 10 kV ________100u; (D) 550x 10 kV
________10u; (E) 600x 10 kV ________10u; (F) 350x 10 kV ________100u.
FIGURE 11 | Scanning electron microscopy of S. mansoni
PZQ-resistant strain adult females of control group kept in RPMI-1640
drug free medium for 3 h. (A,B) Resistant strain adult females kept in
RPMI-1640 drug free medium, showing normal morphology of the oral and
ventral suckers; (C,D) normal morphology of the tegument. Image
marginations: (A) 450x 10 kV ________10u; (B) 2000x 10 kV ________10u;
(C) 950x 10 kV ________10u; (D) 2500x 10 kV ________10u.
FIGURE 12 | Scanning electron microscopy of S. mansoni
PZQ-resistant strain adult females after exposure to 0.3 µM of PZQ for
3 h. (A) Resistant strain adult females upon exposure to PZQ, presenting
changes in oral suckers; (B) light peeling in the worm ventral region; (C,D)
alterations in some tegumental areas. Red arrows indicate alterations. Image
marginations: (A) 220x 10 kV ________100u; (B) 550x 10 kV ________10u;
(C) 160x 10 kV ________100u; (D) 900x 10 kV ________10u.
studies carried out many years ago, tried to clarify the action
mechanisms of the drug used in schistosomiasis treatment. It
was shown that, worms subjected to PZQ, have vacuolization
of the tegument and disruption of the apical tegumental layer
(Becker et al., 1980). Female worms present tegumental damage,
such as, tegument and sub-tegument vacuolization and tegument
and musculature destruction, while male worms show more
pronounced and extensive surface alterations, which include
surface bleeding, swellings, wrinkling, constrictions, and surface
lesions, particularly on the spined tubercles (Shaw and Erasmus,
1983).
As shown by William et al. (2001), our findings demonstrate
that tegumental damage caused by the in vitro effect of PZQ is
much less evident in resistant strain adult worms than in the
susceptible strain. Contrary to what occurs in resistant parasites,
in which PZQ does not seem to cause major damage, males
of the susceptible strain present tegument peeling, tubercle and
spine destruction and vesicles around the tubercles while females
display peeling and wrinkling of the tegument and destruction
of oral and acetabular suckers. These suggest that there might
be a difference in the resistant strain tegument composition that
may render the worms less responsiveness to PZQ. Therefore,
it will be very interesting to perform a more in-depth study of
the resistant strain tegument to see if PZQ resistance might in
any way influence pathology symptomology, since one of the
hallmark effects of PZQ on schistosomes in vitro is the disruption
of surface tegument (William et al., 2001). It is important to
notice that susceptible strain females presentedmuch less damage
than males. This observation is in agreement to the findings from
our previous study where females appearedmore tolerant to PZQ
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(Pinto-Almeida et al., 2015). In the resistant strain, damages on
both males and females were so small that it is far more difficult
to make a similar comparison.
It has been stated in literature that the oviposition of
S. mansoni during in vitro culture of adult worms show three
very distinct phases in the kinetics of oviposition: an initial phase
with low egg production, a period of maximum oviposition and
finally a gradual reduction in the number of eggs during the
last phases of culture (Barth et al., 1996). Liang et al. (2001)
demonstrated that mice infected with PZQ-resistant isolates shed
more eggs in their feces than those carrying drug-susceptible
parasites and mice infected with any of the resistant isolates also
had larger numbers of eggs in their tissues. Mice infected with
our PZQ-resistant strain shed more eggs than those infected by
the counterpart susceptible strain. This is important because if
there is a change in the biological characteristics of schistosomes
associated with the development of resistance to PZQ, it could
affect the transmission and pathology of the diseases they cause
(Liang et al., 2001).
Another interesting finding observed in this study is that
resistant strain eggs were smaller and had a smaller lateral spine
in comparison with eggs from susceptible strain, which may
have repercussions in the pathology of the disease. We have
observed that some mice infected with the PZQ-resistant strain
used here presented some neurological manifestations, including
deviation of the head, tendency to roll over on stimulation, ataxia,
and convulsions, very similar to what is usually seen in mice
affected with cerebral malaria (Lou et al., 2001). Based on this,
it is not unreasonable to speculate that resistant strain parasites
might have altered tissue tropism, namely, a higher tropism for
brain or spinal cord, which may potentiate the development
of neurological manifestations. Clearly, further studies on mice
infected with PZQ-resistant isolates are required to confirm this
hypothesis.
In conclusion, we compared morphological characteristics
of S. mansoni PZQ-resistant and PZQ-susceptible strains upon
addition of this drug in vitro. It was demonstrated that the
resistant strain presents (i) less muscular contractions, (ii) less
tegumental damage, (iii) more viability, and (iv) recovering
motility when the drug is removed, indicating fully active life after
a PZQ treatment is ceased. The resistant strain demonstrated
different eggmorphology when comparedwith susceptible strain.
Those are important findings since any biological changes
can produce relevant alterations in the transmission and
pathology of diseases. Comparing two strains that only differ
in resistance characteristics is an important step in the study
of schistosomiasis as it guarantees that the differences observed
between the two strains are closely related to resistance. Increase
tolerance/resistance to PZQ in an in vivo environment is an
obvious fact and studies should be performed to clarify the
mechanisms associated with it. This study certainly opens doors
for further in-depth S. mansoni drug resistance studies.
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